[Short-term perioperative antibacterial prophylaxis using imipenem-cilastatin versus acylureide penicillins in

N Veneziani1, C De Pasquale, M Baglietto

  • 1Istituto di Cardiochirurgia, Università degli Studi di Bari.

Insights

Short-term imipenem-cilastatin treatment effectively prevented infections in 72 patients undergoing pacemaker procedures. This antibiotic combination demonstrated significant advantages in high-risk patients during a 30-month follow-up period.

Area of Science:

  • Infectious Diseases
  • Cardiology
  • Pharmacology

Background:

  • Pacemaker implantation or substitution carries an inherent risk of infection, particularly in patients with comorbidities.
  • Prophylactic antibiotic strategies are crucial for mitigating infection risk in cardiovascular device procedures.

Purpose of the Study:

  • To evaluate the efficacy and benefits of short-term imipenem-cilastatin therapy in patients undergoing pacemaker surgery.
  • To assess the infection prevention capabilities of this antibiotic combination in a high-risk patient cohort.

Main Methods:

  • A cohort of 72 patients undergoing pacemaker implant or substitution were treated with imipenem-cilastatin.
  • Patients were monitored for infection development over a 30-month follow-up period.

Main Results:

  • The imipenem-cilastatin combination demonstrated high efficacy in preventing infections post-pacemaker procedures.
  • The treatment showed clear advantages in managing infection risk within the studied patient group.

Conclusions:

  • Short-term imipenem-cilastatin treatment is an effective strategy for infection prophylaxis in pacemaker surgery.
  • This antibiotic regimen offers significant benefits for patients at increased risk of infection during cardiovascular device procedures.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...